Means Investment Co., Inc. Moderna, Inc. Transaction History

Means Investment Co., Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 31, 2023	SELL	$118.5 - $160.53 $62,805 - $85,080	-530 Reduced 23.75%	1,702 $206,000
Q1 2023 May 08, 2023	BUY	$135.66 - $197.02 $13,701 - $19,899	101 Added 4.74%	2,232 $342,000
Q4 2022 Jan 27, 2023	SELL	$118.38 - $210.04 $15,981 - $28,355	-135 Reduced 5.96%	2,131 $0
Q3 2022 Oct 17, 2022	SELL	$118.07 - $194.18 $4,722 - $7,767	-40 Reduced 1.73%	2,266 $268,000
Q2 2022 Jul 21, 2022	SELL	$117.13 - $176.59 $20,380 - $30,726	-174 Reduced 7.02%	2,306 $329,000
Q1 2022 Apr 26, 2022	SELL	$126.46 - $235.05 $23,900 - $44,424	-189 Reduced 7.08%	2,480 $427,000
Q4 2021 Feb 14, 2022	BUY	$225.82 - $368.51 $78,811 - $128,609	349 Added 15.04%	2,669 $678,000
Q3 2021 Nov 12, 2021	BUY	$221.9 - $484.47 $87,872 - $191,850	396 Added 20.58%	2,320 $893,000
Q2 2021 Aug 10, 2021	BUY	$129.91 - $234.98 $3,507 - $6,344	27 Added 1.42%	1,924 $452,000
Q1 2021 Apr 05, 2021	BUY	$109.18 - $185.98 $3,384 - $5,765	31 Added 1.66%	1,897 $248,000
Q4 2020 Feb 12, 2021	BUY	$65.74 - $169.86 $122,670 - $316,958	1,866 New	1,866 $342,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Means Investment Co., Inc., based on Form 13F filings with the SEC.

Stay updated on Means Investment Co., Inc. with notifications on news.